Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 84

1.

Pregnancy outcomes in women with gestational diabetes mellitus diagnosed according to the WHO-2013 and WHO-1999 diagnostic criteria: a multicentre retrospective cohort study.

Goedegebure EAR, Koning SH, Hoogenberg K, Korteweg FJ, Lutgers HL, Diekman MJM, Stekkinger E, van den Berg PP, Zwart JJ.

BMC Pregnancy Childbirth. 2018 May 10;18(1):152. doi: 10.1186/s12884-018-1810-5.

2.

Self-tracking of Physical Activity in People With Type 2 Diabetes: A Randomized Controlled Trial.

Kooiman TJM, de Groot M, Hoogenberg K, Krijnen WP, van der Schans CP, Kooy A.

Comput Inform Nurs. 2018 May 4. doi: 10.1097/CIN.0000000000000443. [Epub ahead of print]

PMID:
29742550
3.

HbA1c response after insulin initiation in patients with type 2 diabetes in real-life: identifying distinct subgroups.

Sidorenkov G, van Boven JFM, Hoekstra T, Nijpels G, Hoogenberg K, Denig P.

Diabetes Obes Metab. 2018 Apr 23. doi: 10.1111/dom.13332. [Epub ahead of print]

PMID:
29687577
4.

Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial.

Voormolen DN, DeVries JH, Sanson RME, Heringa MP, de Valk HW, Kok M, van Loon AJ, Hoogenberg K, Bekedam DJ, Brouwer TCB, Porath M, Erdtsieck RJ, NijBijvank B, Kip H, van der Heijden OWH, Elving LD, Hermsen BB, Potter van Loon BJ, Rijnders RJP, Jansen HJ, Langenveld J, Akerboom BMC, Kiewiet RM, Naaktgeboren CA, Mol BWJ, Franx A, Evers IM.

Diabetes Obes Metab. 2018 Mar 30. doi: 10.1111/dom.13310. [Epub ahead of print]

PMID:
29603547
5.

New diagnostic criteria for gestational diabetes mellitus and their impact on the number of diagnoses and pregnancy outcomes.

Koning SH, van Zanden JJ, Hoogenberg K, Lutgers HL, Klomp AW, Korteweg FJ, van Loon AJ, Wolffenbuttel BHR, van den Berg PP.

Diabetologia. 2018 Apr;61(4):800-809. doi: 10.1007/s00125-017-4506-x. Epub 2017 Nov 22.

PMID:
29167927
6.

Liraglutide and Renal Outcomes in Type 2 Diabetes.

Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators.

N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011.

7.

Postpartum glucose follow-up and lifestyle management after gestational diabetes mellitus: general practitioner and patient perspectives.

Koning SH, Lutgers HL, Hoogenberg K, Trompert CA, van den Berg PP, Wolffenbuttel BH.

J Diabetes Metab Disord. 2016 Dec 7;15:56. eCollection 2016.

8.

Neonatal and obstetric outcomes in diet- and insulin-treated women with gestational diabetes mellitus: a retrospective study.

Koning SH, Hoogenberg K, Scheuneman KA, Baas MG, Korteweg FJ, Sollie KM, Schering BJ, van Loon AJ, Wolffenbuttel BH, van den Berg PP, Lutgers HL.

BMC Endocr Disord. 2016 Sep 29;16(1):52.

9.

Risk stratification for healthcare planning in women with gestational diabetes mellitus.

Koning SH, Scheuneman KA, Lutgers HL, Korteweg FJ, van den Berg G, Sollie KM, Roos A, van Loon AJ, Links TP, van Tol KM, Hoogenberg K, van den Berg PP, Wolffenbuttel BH.

Neth J Med. 2016 Jul;74(6):262-9.

10.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators.

N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.

11.

Gestational Diabetes Mellitus:current knowledge and unmet needs.

Koning SH, Hoogenberg K, Lutgers HL, van den Berg PP, Wolffenbuttel BH.

J Diabetes. 2016 Nov;8(6):770-781. doi: 10.1111/1753-0407.12422. Epub 2016 Jul 28. Review.

PMID:
27121958
12.

The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour.

de Boer SA, Lefrandt JD, Petersen JF, Boersma HH, Mulder DJ, Hoogenberg K.

Int J Clin Pharm. 2016 Feb;38(1):144-51. doi: 10.1007/s11096-015-0219-8. Epub 2015 Nov 23.

13.

Mast cell leukaemia presenting with multiple osteoporotic fractures in an elderly woman.

de Boer SE, Hoogenberg K, de Boer NK.

Neth J Med. 2014 Jul;72(6):326-9.

14.

Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets.

DeVries JH, Bain SC, Rodbard HW, Seufert J, D'Alessio D, Thomsen AB, Zychma M, Rosenstock J; Liraglutide-Detemir Study Group.

Diabetes Care. 2012 Jul;35(7):1446-54. doi: 10.2337/dc11-1928. Epub 2012 May 14.

15.

Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial.

Lewis EJ, Lewis JB, Greene T, Hunsicker LG, Berl T, Pohl MA, de Zeeuw D, Heerspink HL, Rohde RD, Atkins RC, Reutens AT, Packham DK, Raz I; Collaborative Study Group.

Am J Kidney Dis. 2011 Nov;58(5):729-36. doi: 10.1053/j.ajkd.2011.06.020. Epub 2011 Aug 26. Erratum in: Am J Kidney Dis. 2012 Feb;59(2):318.

PMID:
21872376
16.

Medication adherence affects treatment modifications in patients with type 2 diabetes.

Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BH, Stolk RP, Denig P; Groningen Initiative to Analyze Type 2 Diabetes Treatment Group.

Clin Ther. 2011 Jan;33(1):121-34. doi: 10.1016/j.clinthera.2011.01.024.

17.

Autonomic dysfunction in diabetes: a consequence of cardiovascular damage.

Lefrandt JD, Smit AJ, Zeebregts CJ, Gans RO, Hoogenberg KH.

Curr Diabetes Rev. 2010 Nov;6(6):348-58. Review.

PMID:
20879972
18.

Identifying targets to improve treatment in type 2 diabetes; the Groningen Initiative to aNalyse Type 2 diabetes Treatment (GIANTT) observational study.

Voorham J, Haaijer-Ruskamp FM, van der Meer K, de Zeeuw D, Wolffenbuttel BH, Hoogenberg K, Denig P; GIANTT-Group.

Pharmacoepidemiol Drug Saf. 2010 Oct;19(10):1078-86. doi: 10.1002/pds.2023.

PMID:
20687048
19.

Intravascular lymphoma as an unusual cause of multifocal cerebral infarctions discovered on FDG-PET/CT.

Boslooper K, Dijkhuizen D, van der Velden AW, Dal M, Meilof JF, Hoogenberg K.

Neth J Med. 2010 Jun;68(6):261-4.

20.

Cardiometabolic treatment decisions in patients with type 2 diabetes: the role of repeated measurements and medication burden.

Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BH, Stolk RP, Denig P; Groningen Initiative to Analyse Type 2 Diabetes Treatment Group.

Qual Saf Health Care. 2010 Oct;19(5):411-5. doi: 10.1136/qshc.2008.030106. Epub 2010 Apr 27.

PMID:
20427303

Supplemental Content

Loading ...
Support Center